HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Dientamoebiasis D004030 1 associated lipids
Adenoma, Oxyphilic D018249 1 associated lipids
Cystadenocarcinoma, Papillary D018283 1 associated lipids
HIV Enteropathy D019053 1 associated lipids
Adenoma, Pleomorphic D008949 1 associated lipids
Nevus, Epithelioid and Spindle Cell D018332 1 associated lipids
Neoplasms, Connective and Soft Tissue D018204 1 associated lipids
Linear IgA Bullous Dermatosis D062027 1 associated lipids
Odontogenic Cyst, Calcifying D018333 1 associated lipids
Congenital Hypothyroidism D003409 1 associated lipids
Equine Infectious Anemia D004859 1 associated lipids
Fetomaternal Transfusion D005331 1 associated lipids
Rhabdomyoma D012207 1 associated lipids
Sarcoma, Endometrial Stromal D018203 1 associated lipids
Prostatic Intraepithelial Neoplasia D019048 1 associated lipids
Schistosomiasis haematobia D012553 1 associated lipids
Angiomyolipoma D018207 1 associated lipids
Granular Cell Tumor D016586 1 associated lipids
Sertoli Cell Tumor D012707 1 associated lipids
Paraganglioma, Extra-Adrenal D010236 1 associated lipids
Tooth Attrition D019217 1 associated lipids
Neoplasms, Fibroepithelial D018225 1 associated lipids
Mesonephroma D008649 1 associated lipids
Acanthamoeba Keratitis D015823 1 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Mercury Poisoning, Nervous System D020262 2 associated lipids
Echinococcosis D004443 2 associated lipids
Glucagonoma D005935 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Vascular Neoplasms D019043 2 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Palatal Neoplasms D010157 2 associated lipids
Mucinoses D017520 2 associated lipids
Choroid Neoplasms D002830 2 associated lipids
Colorectal Neoplasms, Hereditary Nonpolyposis D003123 2 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Candidiasis D002177 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Sarcoma D012509 3 associated lipids
Carcinoma, Mucoepidermoid D018277 3 associated lipids
Embolism D004617 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
Tularemia D014406 3 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Eosinophilic Esophagitis D057765 3 associated lipids
Lip Neoplasms D008048 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Hirschsprung Disease D006627 3 associated lipids
Dysentery, Amebic D004404 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Robinson SP et al. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. 2003 Br. J. Cancer pmid:12771928
Wani KM et al. Genetic alterations in the coding region of the bak gene in uterine cervical carcinoma. 2003 Br. J. Cancer pmid:12771926
Ichikawa W et al. Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. 2004 Br. J. Cancer pmid:15354215
Tsutsui S et al. A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer. 2006 Br. J. Cancer pmid:16721362
Jamerson MH et al. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. 2004 Br. J. Cancer pmid:15354213
Ribatti D et al. Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma. 2006 Br. J. Cancer pmid:16721359
Srivastava S et al. Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression. 2010 Br. J. Cancer pmid:19953094
Barshack I et al. Spectral morphometric characterization of breast carcinoma cells. 1999 Br. J. Cancer pmid:10188915
Aoki S et al. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. 2003 Br. J. Cancer pmid:12618882
Colpaert CG et al. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. 2003 Br. J. Cancer pmid:12618881
Ouyang N et al. Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells. 2010 Br. J. Cancer pmid:20531417
Yoshikawa R et al. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. 2008 Br. J. Cancer pmid:18475300
Martinelli M et al. Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel. 2007 Br. J. Cancer pmid:17848949
Le Page C et al. Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. 2006 Br. J. Cancer pmid:16721361
O'Callaghan G et al. Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells. 2008 Br. J. Cancer pmid:18648368
Salgado R et al. Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer. 2002 Br. J. Cancer pmid:12454774
Elkahwaji JE et al. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. 2009 Br. J. Cancer pmid:19844236
Yamato I et al. Clinical importance of B7-H3 expression in human pancreatic cancer. 2009 Br. J. Cancer pmid:19844235
Nehls O et al. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. 2007 Br. J. Cancer pmid:17426704
Park SW et al. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. 2004 Br. J. Cancer pmid:15266310
Fujimori K et al. Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma. 2005 Br. J. Cancer pmid:15655559
van Hattum AH et al. Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity. 2002 Br. J. Cancer pmid:12237778
Lawson JS et al. Koilocytes indicate a role for human papilloma virus in breast cancer. 2009 Br. J. Cancer pmid:19773762
Watters AD et al. Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer. 2002 Br. J. Cancer pmid:12237776
Mukherjee P et al. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. 2002 Br. J. Cancer pmid:12085212
Semba S et al. Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells. 2009 Br. J. Cancer pmid:19773759
Hoskin PJ et al. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. 2003 Br. J. Cancer pmid:14520462
Janssen CS et al. The T1799A point mutation is present in posterior uveal melanoma. 2008 Br. J. Cancer pmid:18985043
Woodhams JH et al. Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver. 2004 Br. J. Cancer pmid:15266317
Ceelen W et al. Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels. 2007 Br. J. Cancer pmid:17299396
Gisselsson D et al. Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. 2004 Br. J. Cancer pmid:15162157
Liggins AP et al. A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein. 2004 Br. J. Cancer pmid:15162151
Lee YC et al. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers. 2004 Br. J. Cancer pmid:15150628
Wang YF et al. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. 2004 Br. J. Cancer pmid:15150613
Martinho O et al. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. 2009 Br. J. Cancer pmid:19707201
Foster CS et al. Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. 2009 Br. J. Cancer pmid:19707199
Hall GH et al. Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours. 2002 Br. J. Cancer pmid:12085262
Hofman P et al. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. 2008 Br. J. Cancer pmid:18268492
Staal FJ et al. A novel germline mutation of PTEN associated with brain tumours of multiple lineages. 2002 Br. J. Cancer pmid:12085208
Gibcus JH et al. Cortactin expression predicts poor survival in laryngeal carcinoma. 2008 Br. J. Cancer pmid:18268491
Ito Y et al. Expression of cdc25A and cdc25B proteins in thyroid neoplasms. 2002 Br. J. Cancer pmid:12085185
Bignotti E et al. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 2011 Br. J. Cancer pmid:21468050
Hagemann T et al. Molecular profiling of cervical cancer progression. 2007 Br. J. Cancer pmid:17242701
Kommoss S et al. Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. 2007 Br. J. Cancer pmid:17242700
Killeen SD et al. Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, WXC-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases. 2007 Br. J. Cancer pmid:17242699
Stessels F et al. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. 2004 Br. J. Cancer pmid:15054467
Islami F et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. 2004 Br. J. Cancer pmid:15054463
Wang JH et al. Detection of human parvovirus B19 in papillary thyroid carcinoma. 2008 Br. J. Cancer pmid:18212749
Mah-Becherel MC et al. Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model. 2002 Br. J. Cancer pmid:11875746
Hague S et al. Tamoxifen induction of angiogenic factor expression in endometrium. 2002 Br. J. Cancer pmid:11875740
Michel S et al. High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. 2008 Br. J. Cancer pmid:18985040
Adam PJ et al. CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding. 2006 Br. J. Cancer pmid:16892042
Van Valckenborgh E et al. Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. 2002 Br. J. Cancer pmid:11875745
Schrader C et al. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. 2005 Br. J. Cancer pmid:16189522
Shields JD et al. Lymphatic density and metastatic spread in human malignant melanoma. 2004 Br. J. Cancer pmid:14760386
Adib TR et al. Predicting biomarkers for ovarian cancer using gene-expression microarrays. 2004 Br. J. Cancer pmid:14760385
Kang MK et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. 2007 Br. J. Cancer pmid:17179983
Kawaguchi K et al. Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype. 2004 Br. J. Cancer pmid:14760383
Hasuo T et al. Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer. 2007 Br. J. Cancer pmid:17179982
Barros-Silva JD et al. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. 2009 Br. J. Cancer pmid:19156142
Van der Auwera I et al. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. 2008 Br. J. Cancer pmid:18841156
Reddy A et al. Analysis of CHK2 in vulval neoplasia. 2002 Br. J. Cancer pmid:11875739
Cen L et al. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound. 2007 Br. J. Cancer pmid:17848913
Stecker K et al. Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer. 2011 Br. J. Cancer pmid:21468049
Yuen HF et al. Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. 2007 Br. J. Cancer pmid:18000500
Rand V et al. Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma. 2008 Br. J. Cancer pmid:18781180
Senapati S et al. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. 2008 Br. J. Cancer pmid:18781152
Kristiansen G et al. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. 2008 Br. J. Cancer pmid:18781151
Takayama O et al. Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology. 2006 Br. J. Cancer pmid:16969348
Dietze A et al. Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin. 2005 Br. J. Cancer pmid:15886704
Houston A et al. Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression. 2003 Br. J. Cancer pmid:14520470
Hori K and Saito S Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis. 2003 Br. J. Cancer pmid:14520469
Latif Z et al. HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder. 2003 Br. J. Cancer pmid:14520464
Griffiths EA et al. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. 2007 Br. J. Cancer pmid:17179985
Geoerger B et al. Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. 2003 Br. J. Cancer pmid:12888833
Shannon AM et al. Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma. 2005 Br. J. Cancer pmid:15999100
Oosterhoff D et al. Secreted and tumour targeted human carboxylesterase for activation of irinotecan. 2002 Br. J. Cancer pmid:12237777
Kornfeld JW et al. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression. 2011 Br. J. Cancer pmid:21102583
Mimori K et al. Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment. 2006 Br. J. Cancer pmid:16721363
Surowiak P et al. Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. 2006 Br. J. Cancer pmid:16892043
Arrieta O et al. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. 2005 Br. J. Cancer pmid:15785746
Mimura K et al. Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma. 2005 Br. J. Cancer pmid:15785739
Tanaka N et al. Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. 2003 Br. J. Cancer pmid:12888830
Nonomura N et al. Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. 2007 Br. J. Cancer pmid:17848955
Sonoda K et al. Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. 2003 Br. J. Cancer pmid:12888828
Zvereff V et al. Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells. 2007 Br. J. Cancer pmid:17848953
Raccurt M et al. Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. 2003 Br. J. Cancer pmid:12888825
Marikovsky M Thiram inhibits angiogenesis and slows the development of experimental tumours in mice. 2002 Br. J. Cancer pmid:11875743
Landers KA et al. Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. 2008 Br. J. Cancer pmid:18648369
Epping MT et al. PRAME expression and clinical outcome of breast cancer. 2008 Br. J. Cancer pmid:18648365
Maréchal R et al. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. 2009 Br. J. Cancer pmid:19352387
Yu J et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. 2002 Br. J. Cancer pmid:12085263
McCarty MF et al. ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. 2004 Br. J. Cancer pmid:14760388
Manton KJ et al. Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. 2005 Br. J. Cancer pmid:15685234
Hart CA et al. Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. 2005 Br. J. Cancer pmid:15668715
Górka B et al. NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas. 2007 Br. J. Cancer pmid:17667921
Marotta A et al. Characterisation of integrin-linked kinase signalling in sporadic human colon cancer. 2003 Br. J. Cancer pmid:12771992
Minas V et al. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. 2007 Br. J. Cancer pmid:17667919
Nakajima M et al. Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. 2003 Br. J. Cancer pmid:12771989
Charalambous MP et al. Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells. 2003 Br. J. Cancer pmid:12771929